Alnylam Pharmaceuticals
ALNY
#446
Rank
$52.70 B
Marketcap
$398.94
Share price
0.35%
Change (1 day)
63.51%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company